Celldex Therapeutics reported $12.2M in Current Liabilities for its third fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Agenus AGEN:US $ 146.9M 4.62M
Amgen AMGN:US $ 11653M 1700M
Applied Genetic Technologies AGTC:US $ 14.24M 1.23M
Aptinyx Inc APTX:US $ 4.27M 351K
Biocept BIOC:US $ 10.11M 4.48M
Bristol Myers Squibb BMY:US $ 19080M 1384M
Celldex Therapeutics CLDX:US $ 12.2M 1.36M
Glaxosmithkline GSK:US $ 22148M 31M
Immunogen IMGN:US $ 122.32M 22.5M
Newlink Genetics NLNK:US $ 6.96M 35.6M
Rigel Pharmaceuticals RIGL:US $ 34.19M 0.57M
Seattle Genetics SGEN:US $ 388.14M 205M